Consolidated Statement of Changes in Net Equity 

Balance as of January 1, 2012

397.2

168.0

3,813.7

5,237.1

–378.2

0.8

–94.6

1,304.0

10,448.0

46.3

10,494.3

Profit after tax

–

–

–

109.5

–

–

–

–

109.5

5.1

114.6

Other comprehensive income

–

–

–

–

–11.7

0.1

4.5

43.1

36.0

–1.1

34.9

Comprehensive income

–

–

–

109.5

–11.7

0.1

4.5

43.1

145.5

4.0

149.5

Dividend payments

–

–

–

–96.9

–

–

–

–

–96.9

–4.9

–101.8

Profit transfers to/from E. Merck KG including changes in reserves

–

–

–

–8.5

–

–

–

–

–8.5

–

–8.5

Changes in scope of consolidation/Other

–

–

–

–3.1

–

–

–

–

–3.1

3.3

0.2

Balance as of June 30, 2012

397.2

168.0

3,813.7

5,238.1

–389.9

0.9

–90.1

1,347.1

10,485.0

48.7

10,533.7

Balance as of January 1, 2013

397.2

168.0

3,813.7

5,383.9

–645.3

1.2

–29.5

1,272.2

10,361.4

53.4

10,414.8

Profit after tax

–

–

–

582.0

–

–

–

–

582.0

3.1

585.1

Other comprehensive income

–

–

–

–

–36.8

0.3

31.6

–82.1

–87.0

–2.9

–89.9

Comprehensive income

–

–

–

582.0

–36.8

0.3

31.6

–82.1

495.0

0.2

495.2

Dividend payments

–

–

–

–109.9

–

–

–

–

–109.9

–3.0

–112.9

Profit transfers to/from E. Merck KG including changes in reserves

–

–

–

–261.9

–

–

–

–

–261.9

–

–261.9

Transactions with no change of control

–

–

–

2.1

–

–

–

–

2.1

–2.1

–

Changes in scope of consolidation/Other

–

–

–

–1.0

–

–

–

–

–1.0

0.9

–0.1

Balance as of June 30, 2013

397.2

168.0

3,813.7

5,595.2

–682.1

1.5

2.1

1,190.1

10,485.6

49.5

10,535.1